Nigel Sb Rawson

11PUBLICATIONS
16CO-AUTHORS
Clinical pharmacology and therapeuticsMolecular targetsPharmaceutical delivery technologiesChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 29, 2025
Consequences of Canada's Drug Agency Reimbursement Recommendations for New Medicines and Pan-Canadian Pharmaceutical Alliance Price Negotiations on Patient Access.

Nigel S B Rawson

|Sep 27, 2024
Is Canada Moving towards a More Agile Regulatory Approval and Reimbursement Process with a Shifting Role for Real-World Evidence (RWE) for Oncology Drugs?

Catherine Y Lau, Nigel S B Rawson

|May 30, 2024
Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada.

Nigel S B Rawson, David J Stewart

|May 24, 2024
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices.

David J Stewart, John-Peter Bradford, Sandeep Sehdev

|Apr 26, 2024
Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement.

Sandeep R Sehdev, Nigel S B Rawson, Olexiy I Aseyev

|Apr 03, 2024
The impact of willingness-to-pay threshold on price reduction recommendations for oncology drugs: a review of assessments conducted by the Canadian Agency for Drugs and Technologies in Health.

Chakrapani Balijepalli, Lakshmi Gullapalli, Juhi Joshy

Pageof 2

Frequent Collaborators

2 joint publications

Sandeep Sehdev

1 joint publications

Carl D'Arcy

1 joint publications

Marcus O Butler

1 joint publications

Sharlene Gill